Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...

Despite substantial investments in groundbreaking treatments, companies struggle to communicate value early and to the right audience. Here’s how they can do better.

Independent pharmacies applauded legislation that is awaiting the governor’s signature, saying it would help them stay afloat as many of them struggle to survive.

Billy Idol reveals he nearly died of a heroin overdose in London in 1984 in the new documentary 'Billy Idol Should Be Dead,' ...

Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.

From naloxone to drug-checking, harm reduction grows at music festivals—though stigma and laws still pose limits.

Mark Cuban’s Cost Plus Drugs Co. has expanded operations across its drug manufacturing, distribution and partnership enterprises. The company continues to grow its presence in the generic drug market ...

Despite how expensive genAI is right now, there’s an assumption pricing will soar in a year or two — as soon as enterprises ...

Insmed achieved positive phase 2b results for TPIP in PAH. Click here to find out why INSM stock is a Strong Buy.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...

Republican presidential candidate Donald Trump has proposed a “Most Favored Nation” pricing plan to lower the cost of ...